Abstract:
Objective To investigate the epidemiological characteristics, serotype distribution and antimicrobial resistance of non-typhoidal Salmonella (NTS) infection in Zunyi, Guizhou province, and provide evidence for the prevention and treatment NTS infection in this area.
Methods The serotyping, antimicrobial susceptibility test and epidemiological characteristics of NTS isolated in the First People's Hospital of Zunyi from 2020 to 2022 were analyzed.
Results A total of 255 strains of NTS were isolated from 2020 to 2022, of which 33 (12.94%, 33/255) were isolated from blood samples and 222 were isolated from feces samples. The infection rate was higher from May to September (76.86%, 196/255), and infants under 1 year old were susceptible to the infection (59.22%, 151/255). A total of 24 serotypes were detected from 255 NTS isolates, and the predominant serotypes were Salmonella typhimurium (50.59%, 129/255), Salmonella Enteritidis (10.59%, 27/255) and Salmonella Dublin (6.67%, 17/255). The resistance rates of NTS to ampicillin and ampicillin/sulbactam were 79.22% and 68.63%, respectively. The resistance rates to piperacillin/tazobactam, cefepime, imipenem and ertapenem were 3.14%, 5.88%, 0.39% and 0.39%, respectively. The resistance rates of S. Typhimurium to aztreonam, ceftriaxone and levofloxacin were 20.16%, 23.26% and 17.05%, respectively, which were higher than those of S. Enteritidis, the difference was significant (P<0.05). The resistance rates of NTS isolated from stool samples to ampicillin and ampicillin/sulbactam were 83.33% and 71.75%, respectively, which were higher than those of NTS isolated from blood samples, the differences were significant (P<0.001, P=0.002).
Conclusion The incidence of NTS infection was high in summer and autumn in Zunyi during 2020-2022, and NTS was mainly isolated from infants under 1 year old, and S. typhimurium was predominant. The drug resistance of the NTD strains from different sample sources and with different serotypes varied. Antimicrobial agents should be used appropriately according to the serotype, sample type and drug susceptibility results.